United States· US:50474-350_433f8057-35f8-f7e8-e063-6294a90a3ffd
KYGEVVI
A doxecitine and doxribtimine product containing doxecitine; doxribtimine, registered in United States by UCB, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Doxecitine and doxribtimine is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AX29 (doxecitine and doxribtimine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Doxecitine and doxribtimine · ATC A16AX29
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOXECITINE; DOXRIBTIMINE
- Manufacturer
- UCB, Inc.
- Country
- United States (US)
- ATC code
- A16AX29
- ATC class
- Doxecitine and doxribtimine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11504743503030 PACKET in 1 CARTON (50474-350-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (50474-350-01)
- ndc1150474-350-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Doxecitine and doxribtimine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKYGEVVIUCB Pharma SA, Brusel
- FinlandKYGEVVIUCB Pharma SA
- FranceKYGEVVI 2 g/2 g, poudre pour solution buvableUCB PHARMA BELGIQUE
- IrelandKYGEVVI 2 g/2 g powder for oral solutionUCB Pharma S.A.
- IcelandKYGEVVIUCB Pharma S.A.*
- NetherlandsKYGEVVI 2 g/2 g poeder voor drankUCB Pharma S.A.
- SwedenKYGEVVI 2 g/2 g Pulver till oral lösningUCB Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kygevvi
- Liechtenstein · Kygevvi
- Norway · Kygevvi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdd86da1-2b9f-4905-a9b1-e7bcd79f95dc GET /v1/drugs/cdd86da1-2b9f-4905-a9b1-e7bcd79f95dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2; 2",
"substance": "DOXECITINE; DOXRIBTIMINE",
"productndc": "50474-350",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1; g/1",
"application_number": "NDA219792",
"marketing_category": "NDA"
}See everything about doxecitine and doxribtimine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.